CLINICAL AND MORPHOLOGICAL ANALYSIS OF A PULMONARY ALVEOLAR PROTEINOSIS CASE IN AN INFANT

Authors:

Abstract:

This paper presents a clinical case of undiagnosed pulmonary alveolar proteinosis in a 43-day-old child, verified pathomorphologically, including a detailed clinico-morphological analysis. Due to diverse etiopathogenetic mechanisms and non-specific clinical manifestations – specifically, progressive respiratory failure mimicking treatment-resistant interstitial pneumonia – pulmonary alveolar proteinosis remains a significant diagnostic challenge. Early detection is crucial for effective treatment and prognosis. The stages of differential diagnosis, based on the dynamics of clinico-laboratory and instrumental changes, are highlighted. Key diagnostic steps included radiographic detection of bilateral lung opacification without clear focal points and echocardiographic confirmation of severe pulmonary hypertension. A distinctive feature of this case was the paradoxical clinical presentation: the absence of fever and a negative SARS-CoV-2 antigen test despite the mother having moderate COVID-19 at 31–32 weeks of gestation, indicating profound immune reactivity. It was established that the cause of secondary PAP in this child was an immunodeficiency syndrome associated with thymus pathology. The immunodeficiency manifested as a deficiency of cells across all major lymphocyte subpopulations and reduced neutrophil phagocytic activity. Despite intensive therapy, the case was fatal on the 19th day of hospitalization. Pathomorphologically, the diagnosis was confirmed by the presence of PAS-positive eosinophilic material within the alveoli and grade V thymus atrophy.

Keywords:

immunodeficiency etiology differential diagnosis pathomorphology thymus atrophy pulmonary alveolar proteinosis

References:

1. Bush A, Pabary R. Pulmonary alveolar proteinosis in children. Breathe. 2020; 16:200001. doi: https://doi.org/10.1183/20734735.0001-2020.
2. Carrington JM, Hershberger DM. Pulmonary Alveolar Proteinosis; Stat Pearls: St. Petersburg, FL, USA, 2023.
3. Fіlenko BM, Roiko NV, Starchenko II, Proskurnya SA, Nikolenko DY. Clinical and morphological analysis of pulmonary aspergillosis coinfection in COVID-19. Azerbaijan Medical Journal. 2022;2:145–150. doi: https://doi.org/10.34921/amj.2022.2.023.
4. Griese M, Panagiotou P, Manali ED, Stahl M, Schwerk N, Costa V, et al. Autoimmune pulmonary alveolar proteinosis in children. ERJ Open Res 2022;8:00701-2021. doi: https://doi.org/10.1183/23120541.00701-2021.
5. Iftikhar H, Nair GB, Kumar A. Update on Diagnosis and Treatment of Adult Pulmonary Alveolar Proteinosis. Ther. Clin. Risk Manag. 2021;17:701-710. doi: https://doi.org/10.2147/TCRM.S193884.
6. Jayaram IN, Kumar RRBK. Pulmonary alveolar proteinosis in children: An unusual presentation with significant clinical impact. IJPM. 2018; 61(3): 418-20. doi: https://doi.org/10.4103/IJPM.IJPM_17_17.
7. Kumar A, Abdelmalak B, Inoue Y, Culver DA. Pulmonary Alveolar Proteinosis in Adults: Pathophysiology and Clinical Approach. Lancet Respir. Med. 2018;6:554–565. doi: https://doi.org/10.1016/S2213-2600(18)30043-2.
8. McCarthy C, Bonella F, O'Callaghan M, Dupin C, Alfaro T, Fally M, Borie R, et al. European Respiratory Society guidelines for the diagnosis and management of pulmonary alveolar proteinosis. Eur Respir J. 2024;64(5):2400725. doi: https://doi.org/10.1183/13993003.00725-2024.
9. Salvaterra E, Campo I. Pulmonary alveolar proteinosis: from classification to therapy. Breathe. 2020;16(2):200018 doi: https://doi.org/10.1183/20734735.0018-2020.
10. Sisman M, Karapolat S, Topaloglu O, Akdogan A, Turkyilmaz A. A case of pulmonary alveolar proteinosis misdiagnosed as COVID-19 pneumonia. Cirugía y cirujanos. 2022;90(3):402-405. doi: https://doi.org/10.24875/ciru.21000746.
11. Trapnell BC, Nakata K, Bonella F, Campo I, Griese M, Hamilton J, et al. Pulmonary alveolar proteinosis. Nat Rev Dis Primers. 2019;5(1):16. doi: https://doi.org/10.1038/s41572-019-0066-3.
12. Wołoszczak J, Wrześniewska M, Hrapkowicz A, Janowska K, Szydziak J, Gomułka K. A Comprehensive Outlook on Pulmonary Alveolar Proteinosis – A Review. International Journal of Molecular Sciences. 2024; 25(13):7092. doi: https://doi.org/10.3390/ijms25137092.

Publication:

«World of Medicine and Biology» Vol. 21 No. 94 (2025) , с. 276-280
УДК 616.24-008.4-053.2

DOI:

https://doi.org/10.26724/2079-8334-2025-4-94-276-280